Burnaby, Canada

Zongcen Charles Xie


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Zongcen Charles Xie: Innovator in Quantitative Immunoassays**

Introduction

Zongcen Charles Xie is an accomplished inventor based in Burnaby, Canada, recognized for his innovative contributions to the field of quantitative immunoassays. His work focuses on developing methods to accurately measure analytes in fluid samples, advancing the capabilities of diagnostic testing and biomedical research.

Latest Patents

Zongcen Charles Xie holds a patent titled "Compensation for Non-Specific Signals in Quantitative Immunoassays." This patent discloses methods for quantitatively measuring the amount of an analyte of interest in a fluid sample. The patented methods involve the use of membranes with various regions that facilitate the transport and detection of analytes. The approach incorporates test particles and internal control particles to ensure the accuracy of the results. This innovative technique allows researchers to correct the amount of analyte detected based on the differences between the test and control particles, enhancing the reliability of immunoassay tests.

Career Highlights

Zongcen Charles Xie is a vital member of Response Biomedical Corporation, where he applies his expertise in immunoassay technology. His work contributes to the development of cutting-edge diagnostic tools that are essential for monitoring health conditions and conducting biomedical research. With a keen focus on innovation, Xie has made significant strides in the field of medical diagnostics.

Collaborations

Throughout his career, Zongcen Charles Xie has collaborated with several esteemed colleagues, including Donald Elliott Brooks and Paul C. Harris. These partnerships have enabled him to exchange ideas and enhance his research efforts, further driving advancements in the field of immunology and assay technologies.

Conclusion

Zongcen Charles Xie stands out as a dedicated inventor and innovator in the realm of quantitative immunoassays. His patent on compensating for non-specific signals represents a significant advancement in diagnostic methodologies, and his contributions to Response Biomedical Corporation highlight his commitment to improving health outcomes through innovative technologies. As the field of biomedical diagnostics continues to evolve, inventors like Xie will undoubtedly play a crucial role in shaping its future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…